JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

SHA:603235 Revenue

JiangXi Tianxin Pharmaceutical had revenue of 639.76M CNY in the quarter ending March 31, 2026, with 3.37% growth. This brings the company's revenue in the last twelve months to 2.37B, up 1.41% year-over-year. In the year 2025, JiangXi Tianxin Pharmaceutical had annual revenue of 2.35B with 6.18% growth.

• Revenue (ttm): 2.37B
• Revenue Growth: +1.41%
• P/S Ratio: 4.80
• Revenue / Employee: 883.12K
• Employees: 2,679
• Market Cap: 11.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.35B	136.47M	6.18%
Dec 31, 2024	2.21B	326.58M	17.35%
Dec 31, 2023	1.88B	-422.80M	-18.34%
Dec 31, 2022	2.30B	-217.64M	-8.63%
Dec 31, 2021	2.52B	218.84M	9.50%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error